Hampstead Capital as of Sept. 30, 2018
Portfolio Holdings for Hampstead Capital
Hampstead Capital holds 24 positions in its portfolio as reported in the September 2018 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
At&t (T) | 8.6 | $4.8M | 144k | 33.58 | |
Philip Morris International (PM) | 7.2 | $4.0M | 49k | 81.53 | |
PPL Corporation (PPL) | 7.2 | $4.0M | 136k | 29.26 | |
Southern Company (SO) | 7.1 | $4.0M | 92k | 43.60 | |
Coca-Cola Company (KO) | 7.1 | $4.0M | 86k | 46.19 | |
Verizon Communications (VZ) | 7.0 | $3.9M | 74k | 53.39 | |
Pfizer (PFE) | 7.0 | $3.9M | 89k | 44.07 | |
Chevron Corporation (CVX) | 7.0 | $3.9M | 32k | 122.28 | |
Rbc Cad (RY) | 7.0 | $3.9M | 49k | 80.18 | |
Exxon Mobil Corporation (XOM) | 7.0 | $3.9M | 46k | 85.01 | |
Metropcs Communications (TMUS) | 4.3 | $2.4M | 34k | 70.18 | |
Gilead Sciences (GILD) | 2.8 | $1.6M | 21k | 77.22 | |
Dril-Quip (DRQ) | 2.7 | $1.5M | 29k | 52.25 | |
Fluor Corporation (FLR) | 2.4 | $1.4M | 24k | 58.09 | |
American International (AIG) | 2.0 | $1.1M | 22k | 53.26 | |
Franks Intl N V | 1.8 | $1.0M | 118k | 8.68 | |
Merck & Co (MRK) | 1.8 | $993k | 14k | 70.93 | |
Celgene Corporation | 1.8 | $984k | 11k | 89.45 | |
Trinseo S A | 1.7 | $940k | 12k | 78.33 | |
Exelon Corporation (EXC) | 1.6 | $895k | 21k | 43.66 | |
Mylan Nv | 1.5 | $824k | 23k | 36.62 | |
Pioneer Natural Resources (PXD) | 1.4 | $784k | 4.5k | 174.22 | |
Procter & Gamble Company (PG) | 1.1 | $624k | 7.5k | 83.20 | |
General Motors Company (GM) | 0.8 | $471k | 14k | 33.64 |